P
Power Law company profile
Prevail Therapeutics
Biotech & Life Sciences · New York City, United States · Founded 2017 · IPO 2019 Unicorn
Valuation
$1.04B
Market cap · 2026
Global footprint
Where Prevail Therapeutics has talent and traffic
Web traffic by country
680
monthly visits
across markets
across markets
🇺🇸 United States102.9%
Patent intelligence
$20M patent portfolio · 19 active families
Total estimated portfolio value via Dealroom Patent Intelligence (Patsnap), with quality scores compared against same-sector peers.
Estimated portfolio value
$20M
1.9% of market cap · 102.8× smaller than top peer Ablynx ($2B)
19 active patent families
Where Prevail Therapeutics innovates
Molecular biologyLysosomeTransgeneGlucocerebrosidaseCerebroside
Above peer median on Strategic
Quality vs same-sector peers
Prevail Therapeutics on the five Patsnap quality dimensions
Prevail Therapeutics in orange. Same-sector peers are the top filers by total patent value. All scores 0–100; higher is stronger.
Compare against
Patent quality scores (0–100)
Source: Dealroom Patent Intelligence · PatsnapTech-focus vs peers
Where Prevail Therapeutics concentrates inside the peer cluster
Axes are the most-shared Patsnap topics across Prevail Therapeutics and its top peers. Each polygon's reach on an axis = how prominent that topic is in that company's portfolio (#1 topic = 100, #10 = 10, absent = 0).
Compare against
Top-topic prominence (rank inverted, 0–100)
Source: Dealroom Patent Intelligence · Patsnap top-10 topics per companySee Prevail Therapeutics on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.